Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 603415, 5 pages
http://dx.doi.org/10.1155/2014/603415
Research Article

4-Hydroxychalcone Attenuates Hyperaldosteronism, Inflammation, and Renal Injury in Cryptochrome-Null Mice

1Department of Cardiovascular Surgery, The Fourth People’s Hospital of Jinan City, Jinan 250031, China
2Department of Cardiovascular Surgery, Qilu Children’s Hospital of Shandong University, Jinan 250031, China

Received 7 May 2014; Accepted 16 May 2014; Published 9 June 2014

Academic Editor: Chuncho Han

Copyright © 2014 Qi Qu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. A. Calhoun, D. Jones, S. Textor et al., “Resistant hypertension: siagnosis, evaluation, and treatment a scientific statement from the american heart association professional education committee of the council for high blood pressure research,” Hypertension, vol. 51, no. 6, pp. 1403–1419, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. N. Cohn and W. Colucci, “Cardiovascular effects of aldosterone and post-acute myocardial infarction pathophysiology,” American Journal of Cardiology, vol. 97, no. 10, pp. 4–12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. J. W. Funder, “The nongenomic actions of aldosterone,” Endocrine Reviews, vol. 26, no. 3, pp. 313–321, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. E. L. Schiffrin, “Effects of aldosterone on the vasculature,” Hypertension, vol. 47, no. 3, pp. 312–318, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Chapman, J. Dobson, S. Wilson et al., “Effect of spironolactone on blood pressure in subjects with resistant hypertension,” Hypertension, vol. 49, no. 4, pp. 839–845, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Hirai, Y.-I. Kim, T. Goto et al., “Inhibitory effect of naringenin chalcone on inflammatory changes in the interaction between adipocytes and macrophages,” Life Sciences, vol. 81, no. 16, pp. 1272–1279, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. N. J. Lawrence, R. P. Patterson, L.-L. Ooi, D. Cook, and S. Ducki, “Effects of α-substitutions on structure and biological activity of anticancer chalcones,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 22, pp. 5844–5848, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Kimura, M. Taniguchi, and K. Baba, “Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots,” Planta Medica, vol. 70, no. 3, pp. 211–219, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Doi, Y. Takahashi, R. Komatsu et al., “Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6,” Nature Medicine, vol. 16, no. 1, pp. 67–74, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Ni, X.-H. Zhou, H.-H. Li, and W.-F. Huang, “Column chromatographic extraction and preparation of cordycepin from Cordyceps militaris waster medium,” Journal of Chromatography B, vol. 877, no. 22, pp. 2135–2141, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. H. Vitaterna, C. P. Selby, T. Todo et al., “Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 21, pp. 12114–12119, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Alajmi, A. T. Mulgrew, J. Fox et al., “Impact of continuous positive airway pressure therapy on blood pressure inpatientswithobstructive sleepapneahypopnea: ameta-analysis of randomizedcontrolled trials,” Lung, vol. 185, pp. 67–72, 2007. View at Google Scholar
  13. L. Mo and Q. He, “Effect of long-term continuous positive airway pressure ventilation on blood pressure in patients with obstructive sleep apnea hypopnea syndrome: a meta-analysis of clinical trials,” Zhonghua Yi Xue Za Zhi, vol. 87, no. 17, pp. 1177–1180, 2007. View at Google Scholar · View at Scopus
  14. P. Haentjens, A. Van Meerhaeghe, A. Moscariello et al., “The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials,” Archives of Internal Medicine, vol. 167, no. 8, pp. 757–765, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Kim, M. Pham, I. Luttrell et al., “Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity,” Circulation Research, vol. 100, no. 11, pp. 1589–1596, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. P. J. Boyle, “Diabetes mellitus and macrovascular disease: mechanisms and mediators,” American Journal of Medicine, vol. 120, no. 9, pp. S12–S17, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Nigro, N. Osman, A. M. Dart, and P. J. Little, “Insulin resistance and atherosclerosis,” Endocrine Reviews, vol. 27, no. 3, pp. 242–259, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. S. A. Cooper, A. Whaley-Connell, J. Habibi et al., “Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance,” American Journal of Physiology, vol. 293, no. 4, pp. H2009–H2023, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Rodríguez-Iturbe, J. Herrera-Acosta, and R. J. Johnson, “Interstitial inflammation, sodium retention, and the pathogenesis of nephrotic edema: a unifying hypothesis,” Kidney International, vol. 62, no. 4, pp. 1379–1384, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Rodríguez-Iturbe, H. Pons, Y. Quiroz et al., “Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure,” Kidney International, vol. 59, no. 6, pp. 2222–2232, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Shen, F. A. DeLano, B. W. Zweifach, and G. W. Schmid-Schonbein, “Circulating leukocyte counts, activation, and degranulation in Dahl hypertensive rats,” Circulation Research, vol. 76, no. 2, pp. 276–283, 1995. View at Google Scholar · View at Scopus
  22. A.-K. Siegel, P. Kossmehl, M. Planert et al., “Genetic linkage of albuminuria and renal injury in Dahl salt-sensitive rats on a high-salt diet: comparison with spontaneously hypertensive rats,” Physiological Genomics, vol. 18, pp. 218–225, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Alvarez, Y. Quiroz, M. Nava, H. Pons, and B. Rodríguez-Iturbe, “Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells,” American Journal of Physiology, vol. 283, no. 5, pp. F1132–F1141, 2002. View at Google Scholar · View at Scopus
  24. N. Tian, K. D. Thrasher, P. D. Gundy, M. D. Hughson, and R. D. Manning Jr., “Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension,” Hypertension, vol. 45, no. 5, pp. 934–939, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Tian, J.-W. Gu, S. Jordan, R. A. Rose, M. D. Hughson, and R. D. Manning Jr., “Immune suppression prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension,” American Journal of Physiology, vol. 292, no. 2, pp. H1018–H1025, 2007. View at Publisher · View at Google Scholar · View at Scopus